Loading...

Peter Stephen Conti, MD, PhD

Title(s)Professor of Radiology
Phone+1 323 442 3858
vCardDownload vCard
    Other Positions
    Title(s)Director, Molecular Imaging Center

    Title(s)PET Imaging Center Director


    Collapse Overview 
    Collapse Overview
    Dr. Conti completed his MD at Cornell University Medical College and then went on to Cornell University Graduate School of Medicine to do his Ph.D. in Biophysics. After an Internship in Surgery at St. Lukes Hospital, NY he went on to do his residency in Radiology, and then a fellowship in Nuclear Medicine at John Hopkins Hospital, MD. He joined the staff at USC as a professor of Pharmacy and then Radiology and Biomedical Engineering. Dr. Conti as board certification from the the American Board of Radiology and American Board of Nuclear Medicine.

    Collapse Research 
    Collapse Research Activities and Funding
    IVIS Spectrum Optical Imaging Core Resource
    NIH S10OD021785Apr 15, 2017 - Apr 14, 2018
    Role: Principal Investigator
    Phase Contrast Tomographic X-Ray Microscope System
    NIH S10OD018500Apr 6, 2015 - Apr 5, 2016
    Role: Principal Investigator
    Small Animal Photoacoustic Imaging Unit: Integrating Optical Imaging with High Fr
    NIH S10OD018096Jun 1, 2014 - May 31, 2015
    Role: Principal Investigator
    The Tetrazine Ligation for Efficient 18F Labeling and Pretargeted Imaging/Radiotherapy of Cancer
    NIH/NIBIB R01EB014354Sep 23, 2013 - Jun 30, 2017
    Role: Co-Principal Investigator
    MicroPET/CT for Small Animal Imaging
    NIH S10OD012371Apr 20, 2013 - Apr 19, 2014
    Role: Principal Investigator
    EphB4 as Novel Target for Breast Cancer Imaging
    NIH/NIBIB R21EB012294May 1, 2011 - Apr 30, 2014
    Role: Principal Investigator
    Cyclotron for Molecular Imaging Program at USC
    NIH/NCRR S10RR029178May 1, 2011 - Apr 30, 2014
    Role: Principal Investigator
    Ultra-High Resolution CT Specimen Scanner for In Vitro Applications
    NIH/NCRR S10RR027665Jul 1, 2010 - Jun 30, 2011
    Role: Principal Investigator
    Digital X-Ray Device for Molecular Imaging Center
    NIH/NCRR S10RR027689Jul 1, 2010 - Jun 30, 2011
    Role: Principal Investigator
    High Resolution Ultrasound Resource for Molecular Imaging Center
    NIH/NCRR S10RR023653May 1, 2007 - Apr 30, 2008
    Role: Principal Investigator
    Micro Computerized Tomography Imaging System
    NIH/NCRR S10RR019253May 15, 2004 - Dec 30, 2007
    Role: Principal Investigator
    Development of a Cellular and Molecular-Based Cancer Im*
    NIH/NCI P20CA086352Jul 12, 2001 - Jun 30, 2007
    Role: Principal Investigator
    SMALL ANIMAL PET SCANNER FOR CANCER APPLICATIONS
    NIH/NCRR S10RR015703Apr 1, 2001 - Sep 30, 2002
    Role: Principal Investigator
    DUAL HOT CELL SYSTEM AND AUXILLARY EQUIPMENT
    NIH/NCRR S10RR012966Jul 8, 1998 - Jan 7, 2002
    Role: Principal Investigator
    IN VIVO MARKER OF CELL PROLIFERATION FOR PET STUDIES
    NIH/NCI R01CA072896Feb 21, 1997 - Jan 31, 2003
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites
    Collapse Required Scholarly Project Mentor

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Li Y, Zhang J, Gu J, Hu K, Huang S, Conti PS, Wu H, Chen K. Radiofluorinated GPC3-Binding Peptides for PET Imaging of Hepatocellular Carcinoma. Mol Imaging Biol. 2019 May 01. PMID: 31044341.
      View in: PubMed
    2. Zhu J, Li H, Xiong Z, Shen M, Conti PS, Shi X, Chen K. Polyethyleneimine-Coated Manganese Oxide Nanoparticles for Targeted Tumor PET/MR Imaging. ACS Appl Mater Interfaces. 2018 Oct 17; 10(41):34954-34964. PMID: 30234287.
      View in: PubMed
    3. Wang X, Zhang J, Wu H, Li Y, Conti PS, Chen K. PET imaging of Hsp90 expression in pancreatic cancer using a new 64Cu-labeled dimeric Sansalvamide A decapeptide. Amino Acids. 2018 Jul; 50(7):897-907. PMID: 29691700.
      View in: PubMed
    4. Ma W, Fu F, Zhu J, Huang R, Zhu Y, Liu Z, Wang J, Conti PS, Shi X, Chen K. 64Cu-Labeled multifunctional dendrimers for targeted tumor PET imaging. Nanoscale. 2018 Mar 29; 10(13):6113-6124. PMID: 29547220.
      View in: PubMed
    5. Jadvar H, Park R, Yap LP, Chen K, Hughes L, Conti P. Effect of Androgen on Normal Biodistribution of [18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in Athymic Non-tumor-bearing Male Mice. Anticancer Res. 2017 02; 37(2):475-479. PMID: 28179292.
      View in: PubMed
    6. Wang J, Chen F, Arconada-Alvarez SJ, Hartanto J, Yap LP, Park R, Wang F, Vorobyova I, Dagliyan G, Conti PS, Jokerst JV. A Nanoscale Tool for Photoacoustic-Based Measurements of Clotting Time and Therapeutic Drug Monitoring of Heparin. Nano Lett. 2016 Oct 12; 16(10):6265-6271. PMID: 27668964.
      View in: PubMed
    7. Huang R, Conti PS, Chen K. In Vivo Tumor Angiogenesis Imaging Using Peptide-Based Near-Infrared Fluorescent Probes. Methods Mol Biol. 2016; 1444:73-84. PMID: 27283419.
      View in: PubMed
    8. Fang J, Xiao L, Joo KI, Liu Y, Zhang C, Liu S, Conti PS, Li Z, Wang P. A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice. Int J Cancer. 2016 Feb 15; 138(4):1013-23. PMID: 26334777.
      View in: PubMed
    9. Brandhorst S, Choi IY, Wei M, Cheng CW, Sedrakyan S, Navarrete G, Dubeau L, Yap LP, Park R, Vinciguerra M, Di Biase S, Mirzaei H, Mirisola MG, Childress P, Ji L, Groshen S, Penna F, Odetti P, Perin L, Conti PS, Ikeno Y, Kennedy BK, Cohen P, Morgan TE, Dorff TB, Longo VD. A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan. Cell Metab. 2015 Jul 07; 22(1):86-99. PMID: 26094889.
      View in: PubMed
    10. Conti PS. Walter Wolf, PhD, 1931-2014. J Nucl Med. 2015 May; 56(5):13N, 18N. PMID: 25934677.
      View in: PubMed
    11. Wang H, Li D, Liu S, Liu R, Yuan H, Krasnoperov V, Shan H, Conti PS, Gill PS, Li Z. Small-Animal PET Imaging of Pancreatic Cancer Xenografts Using a 64Cu-Labeled Monoclonal Antibody, MAb159. J Nucl Med. 2015 Jun; 56(6):908-13. PMID: 25908833.
      View in: PubMed
    12. Jadvar H, Challa S, Quinn DI, Conti PS. One-Year Postapproval Clinical Experience with Radium-223 Dichloride in Patients with Metastatic Castrate-Resistant Prostate Cancer. Cancer Biother Radiopharm. 2015 Jun; 30(5):195-9. PMID: 25746633.
      View in: PubMed
    13. Selvaraj R, Giglio B, Liu S, Wang H, Wang M, Yuan H, Chintala SR, Yap LP, Conti PS, Fox JM, Li Z. Improved metabolic stability for 18F PET probes rapidly constructed via tetrazine trans-cyclooctene ligation. Bioconjug Chem. 2015 Mar 18; 26(3):435-42. PMID: 25679331.
      View in: PubMed
    14. Huang R, Wang M, Zhu Y, Conti PS, Chen K. Development of PET probes for cancer imaging. Curr Top Med Chem. 2015; 15(8):795-819. PMID: 25732787.
      View in: PubMed
    15. Jadvar H, Desai B, Conti PS. Sodium 18F-fluoride PET/CT of bone, joint, and other disorders. Semin Nucl Med. 2015 Jan; 45(1):58-65. PMID: 25475379.
      View in: PubMed
    16. Ma W, Li G, Wang J, Yang W, Zhang Y, Conti PS, Chen K. In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature. Amino Acids. 2014 Dec; 46(12):2721-32. PMID: 25182731.
      View in: PubMed
    17. Hu LY, Bauer N, Knight LM, Li Z, Liu S, Anderson CJ, Conti PS, Sutcliffe JL. Characterization and evaluation of (64)Cu-labeled A20FMDV2 conjugates for imaging the integrin avß 6. Mol Imaging Biol. 2014 Aug; 16(4):567-77. PMID: 24448825; PMCID: PMC4277820.
    18. Li D, Liu S, Liu R, Park R, Yu H, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. Axl-targeted cancer imaging with humanized antibody h173. Mol Imaging Biol. 2014 Aug; 16(4):511-8. PMID: 24424460.
      View in: PubMed
    19. Li G, Wang X, Zong S, Wang J, Conti PS, Chen K. MicroPET imaging of CD13 expression using a (64)Cu-labeled dimeric NGR peptide based on sarcophagine cage. Mol Pharm. 2014 Nov 03; 11(11):3938-46. PMID: 25054774.
      View in: PubMed
    20. Hu H, Li D, Liu S, Wang M, Moats R, Conti PS, Li Z. Integrin a2ß1 targeted GdVO4:Eu ultrathin nanosheet for multimodal PET/MR imaging. Biomaterials. 2014 Oct; 35(30):8649-58. PMID: 25043573.
      View in: PubMed
    21. Liu S, Li D, Zhang Z, Surya Prakash GK, Conti PS, Li Z. Efficient synthesis of fluorescent-PET probes based on [¹8F]BODIPY dye. Chem Commun (Camb). 2014 Jul 14; 50(55):7371-3. PMID: 24869927.
      View in: PubMed
    22. Liu S, Li D, Guo J, Canale N, Li X, Liu R, Krasnoperov V, Gill PS, Conti PS, Shan H, Li Z. Design, synthesis, and validation of Axl-targeted monoclonal antibody probe for microPET imaging in human lung cancer xenograft. Mol Pharm. 2014 Nov 03; 11(11):3974-9. PMID: 24978094.
      View in: PubMed
    23. Janib SM, Gustafson JA, Minea RO, Swenson SD, Liu S, Pastuszka MK, Lock LL, Cui H, Markland FS, Conti PS, Li Z, MacKay JA. Multimeric disintegrin protein polymer fusions that target tumor vasculature. Biomacromolecules. 2014 Jul 14; 15(7):2347-58. PMID: 24871936.
      View in: PubMed
    24. Wu Z, Liu S, Nair I, Omori K, Scott S, Todorov I, Shively JE, Conti PS, Li Z, Kandeel F. (64)Cu labeled sarcophagine exendin-4 for microPET imaging of glucagon like peptide-1 receptor expression. Theranostics. 2014; 4(8):770-7. PMID: 24955138.
      View in: PubMed
    25. Wu Z, Li L, Liu S, Yakushijin F, Yakushijin K, Horne D, Conti PS, Li Z, Kandeel F, Shively JE. Facile Preparation of a Thiol-Reactive (18)F-Labeling Agent and Synthesis of (18)F-DEG-VS-NT for PET Imaging of a Neurotensin Receptor-Positive Tumor. J Nucl Med. 2014 Jul; 55(7):1178-84. PMID: 24854793.
      View in: PubMed
    26. Liu S, Li Z, Conti PS. Development of multi-functional chelators based on sarcophagine cages. Molecules. 2014 Apr 03; 19(4):4246-55. PMID: 24705567.
      View in: PubMed
    27. Zhu W, Li Q, Bai B, Conti PS, Leahy RM. Patlak image estimation from dual time-point list-mode PET data. IEEE Trans Med Imaging. 2014 Apr; 33(4):913-24. PMID: 24710160.
      View in: PubMed
    28. Li G, Xing Y, Wang J, Conti PS, Chen K. Near-infrared fluorescence imaging of CD13 receptor expression using a novel Cy5.5-labeled dimeric NGR peptide. Amino Acids. 2014 Jun; 46(6):1547-56. PMID: 24652439.
      View in: PubMed
    29. Aluri SR, Shi P, Gustafson JA, Wang W, Lin YA, Cui H, Liu S, Conti PS, Li Z, Hu P, Epstein AL, MacKay JA. A hybrid protein-polymer nanoworm potentiates apoptosis better than a monoclonal antibody. ACS Nano. 2014 Mar 25; 8(3):2064-76. PMID: 24484356.
      View in: PubMed
    30. Fei L, Yap LP, Conti PS, Shen WC, Zaro JL. Tumor targeting of a cell penetrating peptide by fusing with a pH-sensitive histidine-glutamate co-oligopeptide. Biomaterials. 2014 Apr; 35(13):4082-7. PMID: 24508076.
      View in: PubMed
    31. Xing Y, Zhao J, Conti PS, Chen K. Radiolabeled nanoparticles for multimodality tumor imaging. Theranostics. 2014; 4(3):290-306. PMID: 24505237.
      View in: PubMed
    32. Mortimer JE, Bading JR, Colcher DM, Conti PS, Frankel PH, Carroll MI, Tong S, Poku E, Miles JK, Shively JE, Raubitschek AA. Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET. J Nucl Med. 2014 Jan; 55(1):23-9. PMID: 24337604.
      View in: PubMed
    33. Lin Y, Haldar JP, Li Q, Conti PS, Leahy RM. Sparsity Constrained Mixture Modeling for the Estimation of Kinetic Parameters in Dynamic PET. IEEE Trans Med Imaging. 2014 Jan; 33(1):173-85. PMID: 24216681.
      View in: PubMed
    34. Li D, Liu S, Liu R, Zhou Y, Park R, Naga K, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. EphB4-targeted imaging with antibody h131, h131-F(ab')2 and h131-Fab. Mol Pharm. 2013 Dec 02; 10(12):4527-33. PMID: 24147882.
      View in: PubMed
    35. Jang JK, Khawli LA, Park R, Wu BW, Li Z, Canter D, Conti PS, Epstein AL. Cytoreductive chemotherapy improves the biodistribution of antibodies directed against tumor necrosis in murine solid tumor models. Mol Cancer Ther. 2013 Dec; 12(12):2827-36. PMID: 24130055.
      View in: PubMed
    36. Liu S, Li D, Shan H, Gabbaï FP, Li Z, Conti PS. Evaluation of ¹8F-labeled BODIPY dye as potential PET agents for myocardial perfusion imaging. Nucl Med Biol. 2014 Jan; 41(1):120-6. PMID: 24210284.
      View in: PubMed
    37. Bai B, Bading J, Conti PS. Tumor quantification in clinical positron emission tomography. Theranostics. 2013 Oct 07; 3(10):787-801. PMID: 24312151.
      View in: PubMed
    38. Liu R, Li X, Gao W, Zhou Y, Wey S, Mitra SK, Krasnoperov V, Dong D, Liu S, Li D, Zhu G, Louie S, Conti PS, Li Z, Lee AS, Gill PS. Monoclonal antibody against cell surface GRP78 as a novel agent in suppressing PI3K/AKT signaling, tumor growth, and metastasis. Clin Cancer Res. 2013 Dec 15; 19(24):6802-11. PMID: 24048331.
      View in: PubMed
    39. Li D, Liu S, Shan H, Conti P, Li Z. Urokinase plasminogen activator receptor (uPAR) targeted nuclear imaging and radionuclide therapy. Theranostics. 2013; 3(7):507-15. PMID: 23843898.
      View in: PubMed
    40. Jadvar H, Desai B, Ji L, Conti PS, Dorff TB, Groshen SG, Pinski JK, Quinn DI. Baseline 18F-FDG PET/CT parameters as imaging biomarkers of overall survival in castrate-resistant metastatic prostate cancer. J Nucl Med. 2013 Aug; 54(8):1195-201. PMID: 23785174.
      View in: PubMed
    41. Liu S, Li D, Park R, Liu R, Xia Z, Guo J, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. PET imaging of colorectal and breast cancer by targeting EphB4 receptor with 64Cu-labeled hAb47 and hAb131 antibodies. J Nucl Med. 2013 Jul; 54(7):1094-100. PMID: 23667241.
      View in: PubMed
    42. Liu S, Hassink M, Selvaraj R, Yap LP, Park R, Wang H, Chen X, Fox JM, Li Z, Conti PS. Efficient 18F labeling of cysteine-containing peptides and proteins using tetrazine-trans-cyclooctene ligation. Mol Imaging. 2013 Mar-Apr; 12(2):121-8. PMID: 23415400.
      View in: PubMed
    43. Liu S, Lin TP, Li D, Leamer L, Shan H, Li Z, Gabbaï FP, Conti PS. Lewis acid-assisted isotopic 18F-19F exchange in BODIPY dyes: facile generation of positron emission tomography/fluorescence dual modality agents for tumor imaging. Theranostics. 2013; 3(3):181-9. PMID: 23471211.
      View in: PubMed
    44. Cai H, Conti PS. RGD-based PET tracers for imaging receptor integrin av ß3 expression. J Labelled Comp Radiopharm. 2013 May 15; 56(5):264-79. PMID: 24285371.
      View in: PubMed
    45. Joo KI, Xiao L, Liu S, Liu Y, Lee CL, Conti PS, Wong MK, Li Z, Wang P. Crosslinked multilamellar liposomes for controlled delivery of anticancer drugs. Biomaterials. 2013 Apr; 34(12):3098-109. PMID: 23375392; PMCID: PMC3995748.
    46. Wu Z, Liu S, Hassink M, Nair I, Park R, Li L, Todorov I, Fox JM, Li Z, Shively JE, Conti PS, Kandeel F. Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets. J Nucl Med. 2013 Feb; 54(2):244-51. PMID: 23297075.
      View in: PubMed
    47. Liu S, Park R, Conti PS, Li Z. "Kit like" (18)F labeling method for synthesis of RGD peptide-based PET probes. Am J Nucl Med Mol Imaging. 2013; 3(1):97-101. PMID: 23342304.
      View in: PubMed
    48. Janib SM, Liu S, Park R, Pastuszka MK, Shi P, Moses AS, Orosco MM, Lin YA, Cui H, Conti PS, Li Z, MacKay JA. Kinetic quantification of protein polymer nanoparticles using non-invasive imaging. Integr Biol (Camb). 2013 Jan; 5(1):183-94. PMID: 23093022.
      View in: PubMed
    49. Li D, Liu S, Liu R, Park R, Hughes L, Krasnoperov V, Gill PS, Li Z, Shan H, Conti PS. Targeting the EphB4 receptor for cancer diagnosis and therapy monitoring. Mol Pharm. 2013 Jan 07; 10(1):329-36. PMID: 23211050.
      View in: PubMed
    50. Chen K, Ma W, Li G, Wang J, Yang W, Yap LP, Hughes LD, Park R, Conti PS. Synthesis and evaluation of 64Cu-labeled monomeric and dimeric NGR peptides for MicroPET imaging of CD13 receptor expression. Mol Pharm. 2013 Jan 07; 10(1):417-27. PMID: 23190134.
      View in: PubMed
    51. Liu S, Li D, Huang CW, Yap LP, Park R, Shan H, Li Z, Conti PS. Efficient construction of PET/fluorescence probe based on sarcophagine cage: an opportunity to integrate diagnosis with treatment. Mol Imaging Biol. 2012 Dec; 14(6):718-24. PMID: 22476968.
      View in: PubMed
    52. Huang CW, Li Z, Conti PS. Radioactive smart probe for potential corrected matrix metalloproteinase imaging. Bioconjug Chem. 2012 Nov 21; 23(11):2159-67. PMID: 23025637.
      View in: PubMed
    53. Chen K, Wang X, Lin WY, Shen CK, Yap LP, Hughes LD, Conti PS. Strain-Promoted Catalyst-Free Click Chemistry for Rapid Construction of (64)Cu-Labeled PET Imaging Probes. ACS Med Chem Lett. 2012 Dec 13; 3(12):1019-23. PMID: 24900423.
      View in: PubMed
    54. Safdie F, Brandhorst S, Wei M, Wang W, Lee C, Hwang S, Conti PS, Chen TC, Longo VD. Fasting enhances the response of glioma to chemo- and radiotherapy. PLoS One. 2012; 7(9):e44603. PMID: 22984531.
      View in: PubMed
    55. Jadvar H, Yap LP, Park R, Li Z, Chen K, Hughes L, Kouhi A, Conti P. [18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in prostate cancer: initial preclinical observations. Mol Imaging. 2012 Sep-Oct; 11(5):426-32. PMID: 22954187.
      View in: PubMed
    56. Kong N, Lan Q, Su W, Chen M, Wang J, Yang Z, Park R, Dagliyan G, Conti PS, Brand D, Liu Z, Stohl W, Zou H, Zheng SG. Induced T regulatory cells suppress osteoclastogenesis and bone erosion in collagen-induced arthritis better than natural T regulatory cells. Ann Rheum Dis. 2012 Sep; 71(9):1567-1572. PMID: 22764040.
      View in: PubMed
    57. Jadvar H, Desai B, Ji L, Conti PS, Dorff TB, Groshen SG, Gross ME, Pinski JK, Quinn DI. Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer. Clin Nucl Med. 2012 Jul; 37(7):637-43. PMID: 22691503.
      View in: PubMed
    58. Ley EJ, Clond MA, Bukur M, Park R, Chervonski M, Dagliyan G, Margulies DR, Lyden PD, Conti PS, Salim A. ß-adrenergic receptor inhibition affects cerebral glucose metabolism, motor performance, and inflammatory response after traumatic brain injury. J Trauma Acute Care Surg. 2012 Jul; 73(1):33-40. PMID: 22743370.
      View in: PubMed
    59. Angelini A, Di Pietro R, Centurione L, Castellani ML, Conti P, Porreca E, Cuccurullo F. Inhibition of P-glycoprotein-mediated transport by S-adenosylmethionine and cynarin in multidrug-resistant human uterine sarcoma MES-SA/Dx5 cells. J Biol Regul Homeost Agents. 2012 Jul-Sep; 26(3):495-504. PMID: 23034269.
      View in: PubMed
    60. Liu S, Li D, Huang CW, Yap LP, Park R, Shan H, Li Z, Conti PS. The efficient synthesis and biological evaluation of novel bi-functionalized sarcophagine for (64)cu radiopharmaceuticals. Theranostics. 2012; 2(6):589-96. PMID: 22737194.
      View in: PubMed
    61. Ng TS, Bading JR, Park R, Sohi H, Procissi D, Colcher D, Conti PS, Cherry SR, Raubitschek AA, Jacobs RE. Quantitative, simultaneous PET/MRI for intratumoral imaging with an MRI-compatible PET scanner. J Nucl Med. 2012 Jul; 53(7):1102-9. PMID: 22661534; PMCID: PMC3552656.
    62. Chen K, Li Z, Conti PS. Microwave-assisted one-pot radiosynthesis of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-ß-d-arabinofuranosyluracil ([18F]-FMAU). Nucl Med Biol. 2012 Oct; 39(7):1019-25. PMID: 22503457.
      View in: PubMed
    63. Chen K, Sun X, Niu G, Ma Y, Yap LP, Hui X, Wu K, Fan D, Conti PS, Chen X. Evaluation of 64Cu labeled GX1: a phage display peptide probe for PET imaging of tumor vasculature. Mol Imaging Biol. 2012 Feb; 14(1):96-105. PMID: 21360213.
      View in: PubMed
    64. Sahu D, Zhao Z, Tsen F, Cheng CF, Park R, Situ AJ, Dai J, Eginli A, Shams S, Chen M, Ulmer TS, Conti P, Woodley DT, Li W. A potentially common peptide target in secreted heat shock protein-90a for hypoxia-inducible factor-1a-positive tumors. Mol Biol Cell. 2012 Feb; 23(4):602-13. PMID: 22190738.
      View in: PubMed
    65. Li D, Shan H, Conti P, Li Z. PET imaging of metabotropic glutamate receptor subtype 5 (mGluR5). Am J Nucl Med Mol Imaging. 2012; 2(1):29-32. PMID: 23133800.
      View in: PubMed
    66. Li Z, Jin Q, Huang C, Dasa S, Chen L, Yap LP, Liu S, Cai H, Park R, Conti PS. Trackable and Targeted Phage as Positron Emission Tomography (PET) Agent for Cancer Imaging. Theranostics. 2011; 1:371-80. PMID: 22211143.
      View in: PubMed
    67. Huang CW, Li Z, Conti PS. In vivo near-infrared fluorescence imaging of integrin a2ß1 in prostate cancer with cell-penetrating-peptide-conjugated DGEA probe. J Nucl Med. 2011 Dec; 52(12):1979-86. PMID: 22065876.
      View in: PubMed
    68. Liu S, Li Z, Yap LP, Huang CW, Park R, Conti PS. Efficient preparation and biological evaluation of a novel multivalency bifunctional chelator for 64Cu radiopharmaceuticals. Chemistry. 2011 Sep 05; 17(37):10222-5. PMID: 21815227.
      View in: PubMed
    69. Li Z, Lin TP, Liu S, Huang CW, Hudnall TW, Gabbaï FP, Conti PS. Rapid aqueous [18F]-labeling of a bodipy dye for positron emission tomography/fluorescence dual modality imaging. Chem Commun (Camb). 2011 Sep 07; 47(33):9324-6. PMID: 21779546.
      View in: PubMed
    70. Graham M, Conti P, Hoffman J. SNM clinical trials network validates 100th scanner. J Nucl Med. 2011 Jun; 52(6):25N. PMID: 21622892.
      View in: PubMed
    71. Selvaraj R, Liu S, Hassink M, Huang CW, Yap LP, Park R, Fox JM, Li Z, Conti PS. Tetrazine-trans-cyclooctene ligation for the rapid construction of integrin avß3 targeted PET tracer based on a cyclic RGD peptide. Bioorg Med Chem Lett. 2011 Sep 01; 21(17):5011-4. PMID: 21601452.
      View in: PubMed
    72. Zissen MH, Kunz P, Subbarayan M, Chin FT, Conti PS, Fisher GA, Quon A. 18F-5-fluorouracil dynamic positron emission tomography/computed tomography shows decreased tracer activity after bevacizumab in colorectal metastases. Nucl Med Commun. 2011 May; 32(5):343-7. PMID: 21412178.
      View in: PubMed
    73. Huang CW, Li Z, Cai H, Shahinian T, Conti PS. Novel a(2)ß(1) integrin-targeted peptide probes for prostate cancer imaging. Mol Imaging. 2011 Aug; 10(4):284-94. PMID: 21486537.
      View in: PubMed
    74. Cai H, Li Z, Conti PS. The improved syntheses of 5-substituted 2'-[18F]fluoro-2'-deoxy-arabinofuranosyluracil derivatives ([18F]FAU, [18F]FEAU, [18F]FFAU, [18F]FCAU, [18F]FBAU and [18F]FIAU) using a multistep one-pot strategy. Nucl Med Biol. 2011 Jul; 38(5):659-66. PMID: 21718941.
      View in: PubMed
    75. Huang CW, Li Z, Cai H, Chen K, Shahinian T, Conti PS. Design, synthesis and validation of integrin a2ß1-targeted probe for microPET imaging of prostate cancer. Eur J Nucl Med Mol Imaging. 2011 Jul; 38(7):1313-22. PMID: 21350963.
      View in: PubMed
    76. Huang CW, Li Z, Cai H, Shahinian T, Conti PS. Biological stability evaluation of the a2ß1 receptor imaging agents: diamsar and DOTA conjugated DGEA peptide. Bioconjug Chem. 2011 Feb 16; 22(2):256-63. PMID: 21244039.
      View in: PubMed
    77. Chen K, Yap LP, Park R, Hui X, Wu K, Fan D, Chen X, Conti PS. A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice. Amino Acids. 2012 Apr; 42(4):1329-37. PMID: 21212998.
      View in: PubMed
    78. Binns DS, Pirzkall A, Yu W, Callahan J, Mileshkin L, Conti P, Scott AM, Macfarlane D, Fine BM, Hicks RJ. Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2011 Apr; 38(4):642-50. PMID: 21207024.
      View in: PubMed
    79. Cai H, Li Z, Huang CW, Park R, Conti PS. (64)Cu labeled AmBaSar-RGD2 for micro-PET imaging of integrin avß3 expression. Curr Radiopharm. 2011 Jan; 4(1):68-74. PMID: 22191616.
      View in: PubMed
    80. Li Z, Cai H, Conti PS. Improved synthesis of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-ß-D-arabinofuranosyluracil ([18F]FMAU). Curr Radiopharm. 2011 Jan; 4(1):24-30. PMID: 22191612.
      View in: PubMed
    81. Li Z, Cai H, Conti PS. Automated synthesis of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-ß-D-arabinofuranosyluracil ([18F]-FMAU) using a one reactor radiosynthesis module. Nucl Med Biol. 2011 Feb; 38(2):201-6. PMID: 21315275.
      View in: PubMed
    82. Graham M, Conti P, Hoffman J. Clinical trials network strives for standardization. J Nucl Med. 2010 Nov; 51(11):15N. PMID: 21051645.
      View in: PubMed
    83. Li Z, Cai H, Hassink M, Blackman ML, Brown RC, Conti PS, Fox JM. Tetrazine-trans-cyclooctene ligation for the rapid construction of 18F labeled probes. Chem Commun (Camb). 2010 Nov 14; 46(42):8043-5. PMID: 20862423.
      View in: PubMed
    84. Li Z, Conti PS. Radiopharmaceutical chemistry for positron emission tomography. Adv Drug Deliv Rev. 2010 Aug 30; 62(11):1031-51. PMID: 20854860.
      View in: PubMed
    85. Chen K, Conti PS. Target-specific delivery of peptide-based probes for PET imaging. Adv Drug Deliv Rev. 2010 Aug 30; 62(11):1005-22. PMID: 20851156.
      View in: PubMed
    86. Cai H, Li Z, Huang CW, Shahinian AH, Wang H, Park R, Conti PS. Evaluation of copper-64 labeled AmBaSar conjugated cyclic RGD peptide for improved microPET imaging of integrin alphavbeta3 expression. Bioconjug Chem. 2010 Aug 18; 21(8):1417-24. PMID: 20666401.
      View in: PubMed
    87. Lacruz RS, Nanci A, White SN, Wen X, Wang H, Zalzal SF, Luong VQ, Schuetter VL, Conti PS, Kurtz I, Paine ML. The sodium bicarbonate cotransporter (NBCe1) is essential for normal development of mouse dentition. J Biol Chem. 2010 Aug 06; 285(32):24432-8. PMID: 20529845; PMCID: PMC2915679.
    88. Angelini A, Di Ilio C, Castellani ML, Conti P, Cuccurullo F. Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy. J Biol Regul Homeost Agents. 2010 Apr-Jun; 24(2):197-205. PMID: 20487633.
      View in: PubMed
    89. Ley EJ, Park R, Dagliyan G, Palestrant D, Miller CM, Conti PS, Margulies DR, Salim A. In vivo effect of propranolol dose and timing on cerebral perfusion after traumatic brain injury. J Trauma. 2010 Feb; 68(2):353-6. PMID: 20154548.
      View in: PubMed
    90. Cai H, Li Z, Huang CW, Park R, Shahinian AH, Conti PS. An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals. Nucl Med Biol. 2010 Jan; 37(1):57-65. PMID: 20122669.
      View in: PubMed
    91. Li Z, Li Q, Pantazis D, Yu X, Conti PS, Leahy RM. Controlling familywise error rate for matched subspace detection in dynamic FDG PET. IEEE Trans Med Imaging. 2009 Oct; 28(10):1623-31. PMID: 19783499.
      View in: PubMed
    92. McEwan AS, Graham MM, Conti PS. Site qualification in multicenter clinical trials. J Nucl Med. 2009 Aug; 50(8):30N. PMID: 19652215.
      View in: PubMed
    93. Cai H, Fissekis J, Conti PS. Synthesis of a novel bifunctional chelator AmBaSar based on sarcophagine for peptide conjugation and (64)Cu radiolabelling. Dalton Trans. 2009 Jul 21; (27):5395-400. PMID: 19565091.
      View in: PubMed
    94. McEwan AS, Graham MM, Conti PS. SNM molecular imaging summit introduces clinical trials network. J Nucl Med. 2009 Apr; 50(4):18N. PMID: 19339670.
      View in: PubMed
    95. Li Z, Li Q, Yu X, Conti PS, Leahy RM. Lesion detection in dynamic FDG-PET using matched subspace detection. IEEE Trans Med Imaging. 2009 Feb; 28(2):230-40. PMID: 19188110.
      View in: PubMed
    96. Ley EJ, Scehnet J, Park R, Schroff S, Dagliyan G, Conti PS, Margulies DR, Salim A. The in vivo effect of propranolol on cerebral perfusion and hypoxia after traumatic brain injury. J Trauma. 2009 Jan; 66(1):154-9; discussion 159-61. PMID: 19131818.
      View in: PubMed
    97. Bischof Delaloye A, Conti PS, Gisselbrecht C, Gregory SA. New directions in the therapeutic strategy to improve survival outcomes in patients with non-Hodgkin's lymphoma. Introduction. Oncologist. 2009; 14 Suppl 2:1-3. PMID: 19819919.
      View in: PubMed
    98. Bischof Delaloye A, Conti PS, Gisselbrecht C, Gregory SA. New directions in the therapeutic strategy to improve survival outcomes in patients with non-Hodgkin's lymphoma. Summary. Oncologist. 2009; 14 Suppl 2:52-4. PMID: 19819924.
      View in: PubMed
    99. Delbeke D, Stroobants S, de Kerviler E, Gisselbrecht C, Meignan M, Conti PS. Expert opinions on positron emission tomography and computed tomography imaging in lymphoma. Oncologist. 2009; 14 Suppl 2:30-40. PMID: 19819922.
      View in: PubMed
    100. Mouchaty H, Conti R, Conti P, Desogus N, Maleci A, Di Lorenzo N. A one-session circumferential reconstruction in thoracic and lumbar spine fractures using a small expandable cage. J Neurosurg Sci. 2008 Dec; 52(4):101-6; discussion 106. PMID: 18981984.
      View in: PubMed
    101. Jadvar H, Ye W, Groshen S, Conti PS. [F-18]-fluorodeoxyglucose PET-CT of the normal prostate gland. Ann Nucl Med. 2008 Nov; 22(9):787-93. PMID: 19039557.
      View in: PubMed
    102. Wen X, Zou Y, Luo W, Goldberg M, Moats R, Conti PS, Snead ML, Paine ML. Biglycan overexpression on tooth enamel formation in transgenic mice. Anat Rec (Hoboken). 2008 Oct; 291(10):1246-53. PMID: 18727043.
      View in: PubMed
    103. Holschneider DP, Yang J, Sadler TR, Galifianakis NB, Bozorgzadeh MH, Bading JR, Conti PS, Maarek JM. Changes in regional brain perfusion during functional brain activation: comparison of [(64)Cu]-PTSM with [(14)C]-Iodoantipyrine. Brain Res. 2008 Oct 09; 1234:32-43. PMID: 18687316.
      View in: PubMed
    104. Conti PS, McEwan AJ, Pomper MG. Molecular imaging: the future of modern medicine. J Nucl Med. 2008 Jun; 49(6):16N-20N. PMID: 18511813.
      View in: PubMed
    105. Jadvar H, Gurbuz A, Li X, Shahinian A, Conti PS. Choline autoradiography of human prostate cancer xenograft: effect of castration. Mol Imaging. 2008 May-Jun; 7(3):147-52. PMID: 19123985.
      View in: PubMed
    106. Faricelli R, Esposito S, Toniato E, Flacco M, Conti P, Martinotti S, Robuffo I. A new diagnostic approach to better identify antiphospholipid syndrome. Int J Immunopathol Pharmacol. 2008 Apr-Jun; 21(2):387-92. PMID: 18547483.
      View in: PubMed
    107. Jadvar H, Quan V, Henderson RW, Conti PS. [F-18]-Fluorodeoxyglucose PET and PET-CT in diagnostic imaging evaluation of locally recurrent and metastatic bladder transitional cell carcinoma. Int J Clin Oncol. 2008 Feb; 13(1):42-7. PMID: 18307018.
      View in: PubMed
    108. Ulaner GA, Colletti PM, Conti PS. B-cell non-Hodgkin lymphoma: PET/CT evaluation after 90Y-ibritumomab tiuxetan radioimmunotherapy--initial experience. Radiology. 2008 Mar; 246(3):895-902. PMID: 18258810.
      View in: PubMed
    109. Iagaru A, Masamed R, Chawla SP, Menendez LR, Fedenko A, Conti PS. F-18 FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomas. Clin Nucl Med. 2008 Jan; 33(1):8-13. PMID: 18097248.
      View in: PubMed
    110. Zhang QL, Boscolo P, Niu PY, Wang F, Shi YT, Zhang L, Wang LP, Wang J, Di Gioacchino M, Conti P, Li QY, Niu Q. How do rat cortical cells cultured with aluminum die: necrosis or apoptosis? Int J Immunopathol Pharmacol. 2008 Jan-Mar; 21(1):107-15. PMID: 18336736.
      View in: PubMed
    111. Conti PS, Bading JR, Mouton PP, Links JM, Alauddin MM, Fissekis JD, Ravert HT, Hilton J, Wong DF, Anderson JH. In vivo measurement of cell proliferation in canine brain tumor using C-11-labeled FMAU and PET. Nucl Med Biol. 2008 Jan; 35(1):131-41. PMID: 18158952.
      View in: PubMed
    112. Tetè S, Mastrangelo F, Carone L, Nargi E, Costanzo G, Vinci R, Burruano F, Tortorici S, Dadorante V, Caciagli F, Traini T, Gherlone E, Caraffa A, Salini V, Conti P, Ciccarelli R. Morphostructural analysis of human follicular stem cells on highly porous bone hydroxyapatite scaffold. Int J Immunopathol Pharmacol. 2007 Oct-Dec; 20(4):819-26. PMID: 18179737.
      View in: PubMed
    113. Autorino R, Lamendola MG, De Luca G, De Sio M, Giuliano F, D' Armiento M, De Placido S, Conti P, Di Lorenzo G. Neuroendocrine immunophenotype as predictor of clinical recurrence in 110 patients with prostate cancer. Int J Immunopathol Pharmacol. 2007 Oct-Dec; 20(4):765-70. PMID: 18179749.
      View in: PubMed
    114. Wiseman GA, Conti PS, Vo K, Schilder RJ, Gordon LI, Emmanouilides C, Silverman DH, Witzig TE, Darif M, Molina A. Weight-based dosing of Yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma. Clin Lymphoma Myeloma. 2007 Sep; 7(8):514-7. PMID: 18021468.
      View in: PubMed
    115. Liao CP, Zhong C, Saribekyan G, Bading J, Park R, Conti PS, Moats R, Berns A, Shi W, Zhou Z, Nikitin AY, Roy-Burman P. Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence. Cancer Res. 2007 Aug 01; 67(15):7525-33. PMID: 17671224.
      View in: PubMed
    116. Iagaru A, Masamed R, Singer PA, Conti PS. Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2-[F-18]fluoro-D-glucose-PET and PET/CT. Mol Imaging Biol. 2007 Mar-Apr; 9(2):72-7. PMID: 17186139.
      View in: PubMed
    117. Jadvar H, Henderson RW, Conti PS. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma. J Comput Assist Tomogr. 2007 Mar-Apr; 31(2):223-8. PMID: 17414758.
      View in: PubMed
    118. Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti PS. Biodistribution and PET imaging of [(18)F]-fluoroadenosine derivatives. Nucl Med Biol. 2007 Apr; 34(3):267-72. PMID: 17383576.
      View in: PubMed
    119. Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti PS. In vivo evaluation of 2'-deoxy-2'-[(18)F]fluoro-5-iodo-1-beta-D-arabinofuranosyluracil ([18F]FIAU) and 2'-deoxy-2'-[18F]fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil ([18F]FEAU) as markers for suicide gene expression. Eur J Nucl Med Mol Imaging. 2007 Jun; 34(6):822-9. PMID: 17206416.
      View in: PubMed
    120. Iagaru A, Masamed R, Keesara S, Conti PS. Breast MRI and 18F FDG PET/CT in the management of breast cancer. Ann Nucl Med. 2007 Jan; 21(1):33-8. PMID: 17373334.
      View in: PubMed
    121. Iagaru A, Chawla S, Menendez L, Conti PS. 18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas. Nucl Med Commun. 2006 Oct; 27(10):795-802. PMID: 16969262.
      View in: PubMed
    122. Mouchaty H, Conti P, Conti R, Aito S, D'Andrea M, Marinelli C, Di Lorenzo N. Assessment of three year experience of a strategy for patient selection and timing of operation in the management of acute thoracic and lumbar spine fractures: a prospective study. Acta Neurochir (Wien). 2006 Nov; 148(11):1181-7; discussion 1187. PMID: 16960661.
      View in: PubMed
    123. Iagaru A, Masamed R, Singer PA, Conti PS. 2-Deoxy-2-[18F]fluoro-D-glucose-positron emission tomography and positron emission tomography/computed tomography diagnosis of patients with recurrent papillary thyroid cancer. Mol Imaging Biol. 2006 Sep-Oct; 8(5):309-14. PMID: 16758370.
      View in: PubMed
    124. Sodir NM, Chen X, Park R, Nickel AE, Conti PS, Moats R, Bading JR, Shibata D, Laird PW. Smad3 deficiency promotes tumorigenesis in the distal colon of ApcMin/+ mice. Cancer Res. 2006 Sep 01; 66(17):8430-8. PMID: 16951153.
      View in: PubMed
    125. Jadvar H, Henderson RW, Conti PS. 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography imaging evaluation of esophageal cancer. Mol Imaging Biol. 2006 May-Jun; 8(3):193-200. PMID: 16565910.
      View in: PubMed
    126. Chen X, Park R, Khankaldyyan V, Gonzales-Gomez I, Tohme M, Moats RA, Bading JR, Laug WE, Conti PS. Longitudinal microPET imaging of brain tumor growth with F-18-labeled RGD peptide. Mol Imaging Biol. 2006 Jan-Feb; 8(1):9-15. PMID: 16315003.
      View in: PubMed
    127. Ilonidis G, Parapanisiou E, Anogeianaki A, Giavazis I, Theofilogiannakos EK, Tsekoura P, Kidonopoulou K, Trakatelli C, Polimenidis Z, Conti P, Anogianakis G. Interleukin -1beta (IL-1 beta), interleukin 6 (IL-6) and tumor necrosis factor (TNF) in plasma and pleural fluid of pneumonia, lung cancer and tuberculous pleuritis. J Biol Regul Homeost Agents. 2006 Jan-Jun; 20(1-2):41-6. PMID: 18088554.
      View in: PubMed
    128. Chaudhari AJ, Darvas F, Bading JR, Moats RA, Conti PS, Smith DJ, Cherry SR, Leahy RM. Hyperspectral and multispectral bioluminescence optical tomography for small animal imaging. Phys Med Biol. 2005 Dec 07; 50(23):5421-41. PMID: 16306643.
      View in: PubMed
    129. Conti PS, White C, Pieslor P, Molina A, Aussie J, Foster P. The role of imaging with (111)In-ibritumomab tiuxetan in the ibritumomab tiuxetan (zevalin) regimen: results from a Zevalin Imaging Registry. J Nucl Med. 2005 Nov; 46(11):1812-8. PMID: 16269594.
      View in: PubMed
    130. Coleman RE, Delbeke D, Guiberteau MJ, Conti PS, Royal HD, Weinreb JC, Siegel BA, Federle MP, Townsend DW, Berland LL. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the Joint Working Group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. J Am Coll Radiol. 2005 Jul; 2(7):568-84. PMID: 17411882.
      View in: PubMed
    131. Coleman RE, Delbeke D, Guiberteau MJ, Conti PS, Royal HD, Weinreb JC, Siegel BA, Federle MF, Townsend DW, Berland LL. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. J Nucl Med. 2005 Jul; 46(7):1225-39. PMID: 16000293.
      View in: PubMed
    132. Jadvar H, Xiankui L, Shahinian A, Park R, Tohme M, Pinski J, Conti PS. Glucose metabolism of human prostate cancer mouse xenografts. Mol Imaging. 2005 Apr-Jun; 4(2):91-7. PMID: 16105512.
      View in: PubMed
    133. Chen X, Sievers E, Hou Y, Park R, Tohme M, Bart R, Bremner R, Bading JR, Conti PS. Integrin alpha v beta 3-targeted imaging of lung cancer. Neoplasia. 2005 Mar; 7(3):271-9. PMID: 15799827; PMCID: PMC1501139.
    134. Conti PS. The future of radioimmunotherapy: a PET perspective. Semin Oncol. 2005 Feb; 32(1 Suppl 1):S63-7. PMID: 15786028.
      View in: PubMed
    135. Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti PS. Synthesis and evaluation of 2'-deoxy-2'-18F-fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil as a potential PET imaging agent for suicide gene expression. J Nucl Med. 2004 Dec; 45(12):2063-9. PMID: 15585483.
      View in: PubMed
    136. Chen X, Conti PS, Moats RA. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts. Cancer Res. 2004 Nov 01; 64(21):8009-14. PMID: 15520209.
      View in: PubMed
    137. Cham D, Henderson R, Conti PS. Virchow's node on F-18 FDG PET/CT. Clin Nucl Med. 2004 Nov; 29(11):770-2. PMID: 15483511.
      View in: PubMed
    138. Jadvar H, Conti PS. The reproductive tract. Semin Nucl Med. 2004 Oct; 34(4):262-73. PMID: 15493004.
      View in: PubMed
    139. Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. J Nucl Med. 2004 Oct; 45(10):1776-83. PMID: 15471848.
      View in: PubMed
    140. Jadvar H, Gamie S, Ramanna L, Conti PS. Musculoskeletal system. Semin Nucl Med. 2004 Oct; 34(4):254-61. PMID: 15493003.
      View in: PubMed
    141. Chen X, Liu S, Hou Y, Tohme M, Park R, Bading JR, Conti PS. MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides. Mol Imaging Biol. 2004 Sep-Oct; 6(5):350-9. PMID: 15380745.
      View in: PubMed
    142. Chen X, Park R, Hou Y, Tohme M, Shahinian AH, Bading JR, Conti PS. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts. J Nucl Med. 2004 Aug; 45(8):1390-7. PMID: 15299066.
      View in: PubMed
    143. Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti PS. Synthesis of 2'-deoxy-2'-[18F]fluoro-5-bromo-1-beta-D-arabinofuranosyluracil ([18F]-FBAU) and 2'-deoxy-2'-[18F]fluoro-5-chloro-1-beta-D-arabinofuranosyl-uracil ([18F]-FCAU), and their biological evaluation as markers for gene expression. Nucl Med Biol. 2004 May; 31(4):399-405. PMID: 15093809.
      View in: PubMed
    144. Bading JR, Shahinian AH, Vail A, Bathija P, Koszalka GW, Koda RT, Alauddin MM, Fissekis JD, Conti PS. Pharmacokinetics of the thymidine analog 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats. Nucl Med Biol. 2004 May; 31(4):407-18. PMID: 15093810.
      View in: PubMed
    145. Chen X, Park R, Hou Y, Khankaldyyan V, Gonzales-Gomez I, Tohme M, Bading JR, Laug WE, Conti PS. MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide. Eur J Nucl Med Mol Imaging. 2004 Aug; 31(8):1081-9. PMID: 15118844.
      View in: PubMed
    146. Chen X, Tohme M, Park R, Hou Y, Bading JR, Conti PS. Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide. Mol Imaging. 2004 Apr; 3(2):96-104. PMID: 15296674.
      View in: PubMed
    147. Alauddin MM, Shahinian A, Gordon EM, Conti PS. Direct comparison of radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for HSV1-tk expression in a human breast cancer model. Mol Imaging. 2004 Apr; 3(2):76-84. PMID: 15296672.
      View in: PubMed
    148. Chen X, Park R, Shahinian AH, Tohme M, Khankaldyyan V, Bozorgzadeh MH, Bading JR, Moats R, Laug WE, Conti PS. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis. Nucl Med Biol. 2004 Feb; 31(2):179-89. PMID: 15013483.
      View in: PubMed
    149. Conti PS. Radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin): the role of the nuclear medicine physician. Semin Nucl Med. 2004 Jan; 34(1 Suppl 1):2-3. PMID: 14762737.
      View in: PubMed
    150. Chen X, Park R, Tohme M, Shahinian AH, Bading JR, Conti PS. MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide. Bioconjug Chem. 2004 Jan-Feb; 15(1):41-9. PMID: 14733582.
      View in: PubMed
    151. Chen X, Park R, Shahinian AH, Bading JR, Conti PS. Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation. Nucl Med Biol. 2004 Jan; 31(1):11-9. PMID: 14741566.
      View in: PubMed
    152. Huang SH, Frydas S, Conti P, Kempuraj D, Barbacane RC, Grilli A, Boucher W, Letourneau R, Papadopoulou N, Donelan J, Madhappan B, Theoharides TC, De Lutiis MA, Riccioni G, Sabatino G. Interleukin-17: a revisited study. Int J Immunopathol Pharmacol. 2004 Jan-Apr; 17(1):1-4. PMID: 15000860.
      View in: PubMed
    153. Jadvar H, Kherbache HM, Pinski JK, Conti PS. Diagnostic role of [F-18]-FDG positron emission tomography in restaging renal cell carcinoma. Clin Nephrol. 2003 Dec; 60(6):395-400. PMID: 14690256.
      View in: PubMed
    154. Kempuraj D, Frydas S, Conti P, Kandere- Grzybowska K, Boucher W, Letourneau R, Madhappan B, Huang SH, Sugimoto K, Papadopoulou NG, Christodoulou S, Theoharides TC. Interleukin-25 (or IL-17E): a new IL-17 family member with growth factor/inflammatory actions. Int J Immunopathol Pharmacol. 2003 Sep-Dec; 16(3):185-8. PMID: 14611719.
      View in: PubMed
    155. Jadvar H, Pinski JK, Conti PS. FDG PET in suspected recurrent and metastatic prostate cancer. Oncol Rep. 2003 Sep-Oct; 10(5):1485-8. PMID: 12883728.
      View in: PubMed
    156. Bading JR, Yoo PB, Fissekis JD, Alauddin MM, D'Argenio DZ, Conti PS. Kinetic modeling of 5-fluorouracil anabolism in colorectal adenocarcinoma: a positron emission tomography study in rats. Cancer Res. 2003 Jul 01; 63(13):3667-74. PMID: 12839957.
      View in: PubMed
    157. Alauddin MM, Louie AY, Shahinian A, Meade TJ, Conti PS. Receptor mediated uptake of a radiolabeled contrast agent sensitive to beta-galactosidase activity. Nucl Med Biol. 2003 Apr; 30(3):261-5. PMID: 12745017.
      View in: PubMed
    158. Jadvar H, Tatlidil R, Garcia AA, Conti PS. Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography. Clin Radiol. 2003 Mar; 58(3):215-21. PMID: 12639527.
      View in: PubMed
    159. Jadvar H, Conti PS. Diagnostic utility of FDG PET in multiple myeloma. Skeletal Radiol. 2002 Dec; 31(12):690-4. PMID: 12483429.
      View in: PubMed
    160. Tatlidil R, Jadvar H, Bading JR, Conti PS. Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology. 2002 Sep; 224(3):783-7. PMID: 12202714.
      View in: PubMed
    161. Tjuvajev JG, Doubrovin M, Akhurst T, Cai S, Balatoni J, Alauddin MM, Finn R, Bornmann W, Thaler H, Conti PS, Blasberg RG. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J Nucl Med. 2002 Aug; 43(8):1072-83. PMID: 12163634.
      View in: PubMed
    162. Alauddin MM, Shahinian A, Gordon EM, Conti PS. Evaluation of 2'-deoxy-2'-flouro-5-methyl-1-beta-D-arabinofuranosyluracil as a potential gene imaging agent for HSV-tk expression in vivo. Mol Imaging. 2002 Apr-Jun; 1(2):74-81. PMID: 12920847.
      View in: PubMed
    163. Wagner HN, Wiseman GA, Marcus CS, Nabi HA, Nagle CE, Fink-Bennett DM, Lamonica DM, Conti PS. Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with (90)Y-labeled anti-CD20 monoclonal antibody. J Nucl Med. 2002 Feb; 43(2):267-72. PMID: 11850494.
      View in: PubMed
    164. Cappellani A, Zanghì A, Di Vita M, Menzo EL, Conti P. Nonparasitic cysts of the liver: laparoscopic treatment and long-term results. Ann Ital Chir. 2002 Jan-Feb; 73(1):85-8; discussion 89. PMID: 12148428.
      View in: PubMed
    165. Alauddin MM, Shahinian A, Gordon EM, Bading JR, Conti PS. Preclinical evaluation of the penciclovir analog 9-(4-[(18)F]fluoro-3-hydroxymethylbutyl)guanine for in vivo measurement of suicide gene expression with PET. J Nucl Med. 2001 Nov; 42(11):1682-90. PMID: 11696640.
      View in: PubMed
    166. Tatlidil R, Conti PS, Conti P. Gastric and colonic bypass grafts: FDG positron emission tomographic patterns. Clin Nucl Med. 2001 Nov; 26(11):955-6. PMID: 11595859.
      View in: PubMed
    167. Keppler JS, Conti PS. A cost analysis of positron emission tomography. AJR Am J Roentgenol. 2001 Jul; 177(1):31-40. PMID: 11418393.
      View in: PubMed
    168. Tamiz AP, Conti P, Zhang M, Johnson KM, Kozikowski AP. A convenient procedure for the synthesis of nonsymmetrical bivalent selective serotonin reuptake inhibitors using polymer-supported reagents. Bioorg Med Chem Lett. 2000 Dec 18; 10(24):2741-3. PMID: 11133081.
      View in: PubMed
    169. Bading JR, Alauddin MM, Fissekis JD, Shahinian AH, Joung J, Spector T, Conti PS. Blocking catabolism with eniluracil enhances PET studies of 5-[18F]fluorouracil pharmacokinetics. J Nucl Med. 2000 Oct; 41(10):1714-24. PMID: 11038003.
      View in: PubMed
    170. Bading JR, Shahinian AH, Bathija P, Conti PS. Pharmacokinetics of the thymidine analog 2'-fluoro-5-[(14)C]-methyl-1-beta-D-arabinofuranosyluracil ([(14)C]FMAU) in rat prostate tumor cells. Nucl Med Biol. 2000 May; 27(4):361-8. PMID: 10938471.
      View in: PubMed
    171. Conti PS, Keppler J. New indications give PET a lift after struggle over regulatory and reimbursement issues. Diagn Imaging (San Franc). 2000 Jan; 22(1):40-7. PMID: 10848425.
      View in: PubMed
    172. Felaco M, Reale M, Grilli A, De Lutiis MA, Barbacane RC, Di Luzio S, Conti P. Impact of extremely low frequency electromagnetic fields on CD4 expression in peripheral blood mononuclear cells. Mol Cell Biochem. 1999 Nov; 201(1-2):49-55. PMID: 10630622.
      View in: PubMed
    173. Conti PS, Durski JM, Bacqai F, Grafton ST, Singer PA. Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography. Thyroid. 1999 Aug; 9(8):797-804. PMID: 10482373.
      View in: PubMed
    174. Alauddin MM, Shahinian A, Kundu RK, Gordon EM, Conti PS. Evaluation of 9-[(3-18F-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors. Nucl Med Biol. 1999 May; 26(4):371-6. PMID: 10382839.
      View in: PubMed
    175. Powars DR, Conti PS, Wong WY, Groncy P, Hyman C, Smith E, Ewing N, Keenan RN, Zee CS, Harold Y, Hiti AL, Teng EL, Chan LS. Cerebral vasculopathy in sickle cell anemia: diagnostic contribution of positron emission tomography. Blood. 1999 Jan 01; 93(1):71-9. PMID: 9864148.
      View in: PubMed
    176. Keppler JS, Thornberg CF, Conti PS. Regulation of positron emission tomography: a case study. AJR Am J Roentgenol. 1998 Nov; 171(5):1187-92. PMID: 9798844.
      View in: PubMed
    177. Schmall B, Conti PS, Schaeffer DJ, Kleinert EL. Radiotracer-derived biochemical profiles via a mathematical model: implications for therapeutic intervention. Nucl Med Biol. 1998 Nov; 25(8):799-801. PMID: 9863569.
      View in: PubMed
    178. Muggia FM, Conti PS. Seminoma and sarcoidosis: a cause for false positive mediastinal uptake in PET? Ann Oncol. 1998 Aug; 9(8):924. PMID: 9789621.
      View in: PubMed
    179. Conti P, Dallanoce C, De Amici M, De Micheli C, Klotz KN. Synthesis of new delta 2-isoxazoline derivatives and their pharmacological characterization as beta-adrenergic receptor antagonists. Bioorg Med Chem. 1998 Apr; 6(4):401-8. PMID: 9597184.
      View in: PubMed
    180. Alauddin MM, Conti PS. Synthesis and preliminary evaluation of 9-(4-[18F]-fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG): a new potential imaging agent for viral infection and gene therapy using PET. Nucl Med Biol. 1998 Apr; 25(3):175-80. PMID: 9620620.
      View in: PubMed
    181. Alauddin MM, Fissekis JD, Conti PS. Alpha-alkylation of amino acid derivatives: synthesis and chiral resolution of [11C]beta-aminoisobutyric acid. Nucl Med Biol. 1997 Nov; 24(8):771-5. PMID: 9428604.
      View in: PubMed
    182. Muderspach L, Muggia FM, Conti PS. Second-look laparotomy for stage III epithelial ovarian cancer: rationale and current issues. Cancer Treat Rev. 1996 Nov; 21(6):499-511. PMID: 8599801.
      View in: PubMed
    183. Conti PS, Lilien DL, Hawley K, Keppler J, Grafton ST, Bading JR. PET and [18F]-FDG in oncology: a clinical update. Nucl Med Biol. 1996 Aug; 23(6):717-35. PMID: 8940714.
      View in: PubMed
    184. Bading JR, Kan-Mitchell J, Conti PS. System A amino acid transport in cultured human tumor cells: implications for tumor imaging with PET. Nucl Med Biol. 1996 Aug; 23(6):779-86. PMID: 8940721.
      View in: PubMed
    185. Alauddin MM, Conti PS, Mazza SM, Hamzeh FM, Lever JR. 9-[(3-[18F]-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG): a potential imaging agent of viral infection and gene therapy using PET. Nucl Med Biol. 1996 Aug; 23(6):787-92. PMID: 8940722.
      View in: PubMed
    186. Schmall B, Conti PS, Alauddin MM. Synthesis of [11C-methyl]-alpha-aminoisobutyric acid (AIB). Nucl Med Biol. 1996 Apr; 23(3):263-6. PMID: 8782235.
      View in: PubMed
    187. Alauddin MM, Ravert HT, Musachio JL, Mathews WB, Dannals RF, Conti PS. Selective alkylation of pyrimidyl dianions III: no-carrier-added synthesis of [11C-methyl]-thymidine. Nucl Med Biol. 1995 Aug; 22(6):791-4. PMID: 8535340.
      View in: PubMed
    188. Conti PS, Alauddin MM, Fissekis JR, Schmall B, Watanabe KA. Synthesis of 2'-fluoro-5-[11C]-methyl-1-beta-D-arabinofuranosyluracil ([11C]-FMAU): a potential nucleoside analog for in vivo study of cellular proliferation with PET. Nucl Med Biol. 1995 Aug; 22(6):783-9. PMID: 8535339.
      View in: PubMed
    189. Conti PS. Introduction to imaging brain tumor metabolism with positron emission tomography (PET). Cancer Invest. 1995; 13(2):244-59. PMID: 7874578.
      View in: PubMed
    190. Conti PS, Hilton J, Wong DF, Alauddin MM, Dannals RF, Ravert HT, Wilson AA, Anderson JH. High performance liquid chromatography of carbon-11 labeled thymidine and its major catabolites for clinical PET studies. Nucl Med Biol. 1994 Nov; 21(8):1045-51. PMID: 9234362.
      View in: PubMed
    191. Conti PS, Keppler JS, Halls JM. Positron emission tomography: a financial and operational analysis. AJR Am J Roentgenol. 1994 Jun; 162(6):1279-86. PMID: 8191981.
      View in: PubMed
    192. Anderson JH, Strandberg JD, Wong DF, Conti PS, Barker PB, Blackband SJ, Hilton J, Natarajan TK, Dannals RF, Samphilipo MA. Multimodality correlative study of canine brain tumors. Proton magnetic resonance spectroscopy, positron emission tomography, and histology. Invest Radiol. 1994 Jun; 29(6):597-605. PMID: 8088967.
      View in: PubMed
    193. Conti PS. Positron emission tomography in clinical oncology. West J Med. 1994 May; 160(5):453-4. PMID: 8048230.
      View in: PubMed
    194. Couldwell WT, Weiss MH, DeGiorgio CM, Weiner LP, Hinton DR, Ehresmann GR, Conti PS, Apuzzo ML. Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen. Neurosurgery. 1993 Mar; 32(3):485-9; discussion 489-90. PMID: 8384328.
      View in: PubMed
    195. Brust P, Shaya EK, Jeffries KJ, Dannals RF, Ravert HT, Wilson AA, Conti PS, Wagner HN, Gjedde A, Ermisch A. Effects of vasopressin on blood-brain transfer of methionine in dogs. J Neurochem. 1992 Oct; 59(4):1421-9. PMID: 1402892.
      View in: PubMed
    196. Conti P, Panara MR, Porrini AM, Gambi D, Barbacane RC, Reale M, Bongrazio M, Dempsey RA. Inhibition of interleukin-1 (alpha and beta), interleukin-2 secretion and surface expression of interleukin-2 receptor (IL-2R) by a novel cytokine interleukin-1 receptor antagonist (IL-1ra). Scand J Immunol. 1992 Jul; 36(1):27-33. PMID: 1535451.
      View in: PubMed
    197. Schmall B, Conti PS, Schaeffer DJ, Kleinert EL. Tumor and organ biochemical profiles determined in vivo following uptake of a combination of radiolabeled substrates: potential applications for PET. Am J Physiol Imaging. 1992 Jan-Mar; 7(1):2-11. PMID: 1520503.
      View in: PubMed
    198. Sordillo PP, DiResta GR, Fissekis J, Conti P, Benua RS, Yeh SD, Laughlin JS. Tumor imaging with carbon-11 labeled alpha-aminoisobutyric acid (AIB) in patients with malignant melanoma. Am J Physiol Imaging. 1991 Oct-Dec; 6(4):172-5. PMID: 1817569.
      View in: PubMed
    199. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med. 1991 Apr; 32(4):623-48; discussion 649-50. PMID: 2013803.
      View in: PubMed
    200. Wagner HN, Conti PS. Advances in medical imaging for cancer diagnosis and treatment. Cancer. 1991 Feb 15; 67(4 Suppl):1121-8. PMID: 1991270.
      View in: PubMed
    201. Ridge JA, Collin C, Bading JR, Hancock C, Conti PS, Daly JM, Raaf JH. Increased adriamycin levels in hepatic implants of rabbit Vx-2 carcinoma from regional infusion. Cancer Res. 1988 Aug 15; 48(16):4584-7. PMID: 3396009.
      View in: PubMed
    202. Conti PS, Warner CH, Fleisher AG, Nay HR, Jones B. Bowel obstruction caused by gastric balloons. AJR Am J Roentgenol. 1988 Aug; 151(2):313-4. PMID: 3293375.
      View in: PubMed
    203. Starnes HF, Conti PS, Warren RS, Jeevanandam M, Brennan MF. Altered peripheral amino acid uptake in obstructive jaundice. J Surg Res. 1987 Apr; 42(4):383-93. PMID: 3553743.
      View in: PubMed
    204. Schmall B, Conti PS, Bigler RE, Zanzonico PB, Reiman RE, Benua RS, Yeh SD, Dahl JR, Lee R, Laughlin JS. Imaging studies of patients with malignant fibrous histiocytoma using C-11-alpha-aminoisobutyric acid (AIB). Clin Nucl Med. 1987 Jan; 12(1):22-6. PMID: 3028690.
      View in: PubMed
    205. Conti PS, Sordillo PP, Sordillo EM, Schmall B. Tumor localization of the metabolically trapped radiolabeled substrates 2-deoxy-D-glucose and aminocyclopentanecarboxylic acid in human melanoma heterotransplants. Am J Clin Oncol. 1986 Dec; 9(6):537-40. PMID: 3491534.
      View in: PubMed
    206. Conti PS, Sordillo PP, Schmall B, Benua RS, Bading JR, Bigler RE, Laughlin JS. Tumor imaging with carbon-11 labeled alpha-aminoisobutyric acid (AIB) in a patient with advanced malignant melanoma. Eur J Nucl Med. 1986; 12(7):353-6. PMID: 3792366.
      View in: PubMed
    207. Conti PS, Sordillo EM, Sordillo PP, Schmall B. Tumor localization of alpha-aminoisobutyric acid (AIB) in human melanoma heterotransplants. Eur J Nucl Med. 1985; 10(1-2):45-7. PMID: 3979409.
      View in: PubMed
    208. Bigler RE, Zanzonico PB, Schmall B, Conti PS, Dahl JR, Rothman L, Sgouros G, MacEwen EG. Evaluation of [1-11C]-alpha-aminoisobutyric acid for tumor detection and amino acid transport measurement: spontaneous canine tumor studies. Eur J Nucl Med. 1985; 10(1-2):48-55. PMID: 3979410.
      View in: PubMed
    209. Herr HW, Kleinert EL, Conti PS, Burchenal JH, Whitmore WF. Effects of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) on the growth of experimental renal adenocarcinoma in mice. Cancer Res. 1984 Oct; 44(10):4382-5. PMID: 6432312.
      View in: PubMed
    210. Sundoro-Wu BM, Schmall B, Conti PS, Dahl JR, Drumm P, Jacobsen JK. Selective alkylation of pyrimidyldianions: synthesis and purification of 11C labeled thymidine for tumor visualization using positron emission tomography. Int J Appl Radiat Isot. 1984 Aug; 35(8):705-8. PMID: 6332784.
      View in: PubMed
    211. Conti PS, Schmall B, Bigler RE, Zanzonico PB, Reiman RE, Dahl JR, Jacobsen JK, Lee R, Winstead MB. Synthesis and purification of sodium [11C]benzoate for physiological and metabolic studies: evaluation in a tumor-bearing dog. Int J Nucl Med Biol. 1984; 11(2):179-83. PMID: 6592159.
      View in: PubMed
    212. Schmall B, Conti PS, Bigler RE, Zanzonico PB, Dahl JR, Sundoro-Wu BM, Jacobsen JK, Lee R. Synthesis and quality assurance of [11C]alpha-aminoisobutyric acid (AIB), a potential radiotracer for imaging and amino acid transport studies in normal and malignant tissues. Int J Nucl Med Biol. 1984; 11(3-4):209-14. PMID: 6530341.
      View in: PubMed
    213. Perlman ME, Conti PS, Schmall B, Watanabe KA. Synthesis and purification of the anti-viral agent 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine (FIAC) labeled with iodine-125. Int J Nucl Med Biol. 1984; 11(3-4):215-8. PMID: 6530342.
      View in: PubMed
    214. Dunzendorfer U, Schmall B, Bigler RE, Zanzonico PB, Conti PS, Dahl JR, Kleinert E, Whitmore WF. Synthesis and body distribution of alpha-aminoisobutyric acid-L-11C in normal and prostate cancer-bearing rat after chemotherapy. Eur J Nucl Med. 1981; 6(11):535-8. PMID: 7327192.
      View in: PubMed
    215. Burns HD, Marzilli LG, Dannals RF, Dannals TE, Trageser TC, Conti P, Wagner HN. 4-[125I] iodophenyltrimethylammonium ion, an iodinated acetylcholinesterase inhibitor with potential as a myocardial imaging agent. J Nucl Med. 1980 Sep; 21(9):875-9. PMID: 7411220.
      View in: PubMed